Revenue - NanJing Pharmaceutical Co Ltd (SSE:600713) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 4.86 CNY 1.89%

Updated:

NanJing Pharmaceutical Co Ltd
Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

NanJing Pharmaceutical Co Ltd
Revenue Peer Comparison

1099

S

601607

600998

C

600511

000963

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
	NanJing Pharmaceutical Co Ltd SSE:600713	Revenue ¥53.3B	CAGR 3-Years 11%	CAGR 5-Years 11%	CAGR 10-Years 11%
	Sinopharm Group Co Ltd HKEX:1099	Revenue ¥591.6B	CAGR 3-Years 11%	CAGR 5-Years 12%	CAGR 10-Years 15%
S	Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	Revenue ¥260.3B	CAGR 3-Years 11%	CAGR 5-Years 10%	CAGR 10-Years 13%
	Jointown Pharmaceutical Group Co Ltd SSE:600998	Revenue ¥151.8B	CAGR 3-Years 13%	CAGR 5-Years 13%	CAGR 10-Years 17%
C	China National Medicines Corp Ltd SSE:600511	Revenue ¥49.7B	CAGR 3-Years 7%	CAGR 5-Years 5%	CAGR 10-Years 17%
	Huadong Medicine Co Ltd SZSE:000963	Revenue ¥40.3B	CAGR 3-Years 7%	CAGR 5-Years 6%	CAGR 10-Years 10%

See Also

Based on the financial report for Sep 30, 2023, NanJing Pharmaceutical Co Ltd's Revenue amounts to 53.3B CNY.

Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for NanJing Pharmaceutical Co Ltd have been 11% over the past three years , 11% over the past five years , and 11% over the past ten years .

Join more than 133,800+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.